The clinical significance of anti-fibrillarin (u3-rnp) antibodies in systemic sclerosis

Zaripov S.I. Abdurakhmanova N.M. Pulotova S.A.

dc.contributor.author	Zaripov S.I. Abdurakhmanova N.M. Pulotova S.A.
dc.date.accessioned	2023-06-13T05:49:49Z
dc.date.available	2023-06-13T05:49:49Z
dc.date.issued	2023
dc.identifier.citation	Тошкент	en_US
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/8365
dc.description.abstract	Systemic sclerosis is a chronic autoimmune connective tissue disease, characterized by endothelial dysfunction, immune abnormalities and progressive fibrosis of skin and multiple inner organs. The main marker of an abnormal immune response is circulating autoantibodies, which are found in more than 95% of patients with systemic sclerosis. It is important to study the clinical, immunological, diagnostic and prognostic significance of autoantibodies, especially anti-fibrillarin antibodies produced against the fibrillarin protein.	en_US
dc.language.iso	en	en_US
dc.subject	To study the clinical significance of anti-fibrillarin (U3-RNP) antibodies in systemic sclerosis.	en_US
dc.title	The clinical significance of anti-fibrillarin (u3-rnp) antibodies in systemic sclerosis	en_US
dc.type	Thesis	en_US